TeamBest Global/Best Theratronics, Ltd. To Ship India Its First GammaBeam System For Cancer Treatment Patients

TeamBest Global/Best Theratronics, Ltd. To Ship India Its First GammaBeam System For Cancer Treatment Patients

Washington, DC, USA – January 18, 2024

TeamBest Global (TBG) and Best Theratronics, Ltd. (BTL) Ottawa, Ontario, Canada have collaborated to introduce the world's very first GammaBeam Teletherapy System with IMRT, SBRS combined with Active Rx Treatment Plans with a built-in electronic Multi-Leaf Collimator (MLC).  The first system is scheduled to be shipped to Coimbatore, India to establish the First Best Cure Foundation Society — a non-profit organization in India.  Best Cure Foundation, a non-profit and non-governmental organization based in Canada and the USA, is paying for this unit, including shipping it this month.

The system is set to arrive in Coimbatore by the end of March 2024 at the Cancer Center.  With this new technology, it is expected to be operational by the end of the second quarter.  The installation and commissioning process will take around two months.  Once the High Specific Activity Cobalt-60 Source is loaded, it will secure approval from the Indian Regulatory Authority, Atomic Energy Regulatory Board (AERB) after commissioning, before cancer patients can receive treatment 24/7.

In 1951, Theratronics, Ltd., a Crown Corp. of Atomic Energy of Canada, Ltd., AECL invented the world's very first Cobalt/GammaBeam Teletherapy System for the treatment of cancer.  Canada Post issued a stamp in recognition of this achievement.

Theratronics, Ottawa was acquired by Dr. Krishnan Suthanthiran, President/Founder of TBG, in May 2008 and renamed BTL.  It was then merged with Nomos Corporation, Pittsburgh, PA (acquired by TBG in September 2007) and renamed Best Nomos.  Best Nomos is known for its inventions of IMRT/Serial Tomotherapy, and Active RX and SBRS Treatment Planning Programs for curative cancer treatment.  Their inventions are widely used globally for treating curative cancer and palliative care.

For more information, please click here to view the original press release.

Click here to download the PDF.